Single dose of Johnson & Johnson vaccine is 66% effective, say U.S. regulators

Johnson & Johnson's one-shot COVID-19 vaccine appeared safe and effective in trials, U.S. Food and Drug Administration staff said in documents published on Wednesday, paving the way for its approval for emergency use.